Research Involving Recombinant DNA Molecules Sample Clauses

Research Involving Recombinant DNA Molecules. If this award supports research involving recombinant DNA molecules, the awardee agrees to comply with the requirements of AAG Chapter VI.B.2.
AutoNDA by SimpleDocs
Research Involving Recombinant DNA Molecules. Any Recipient performing research involving recombinant DNA molecules and/or organism and viruses containing recombinant DNA molecules agrees, by acceptance of this award, to comply with the National Institutes of Health “Guidelines for Research Involving Recombinant DNA Molecules,” July5, 1994 (59 FR 34496) as amended, or such later revision of those guidelines as may be published in the Federal Register.
Research Involving Recombinant DNA Molecules. ‌ If this award supports research involving recombinant DNA molecules, the awardee agrees to comply with the requirements of AAG Chapter VI.B.2. 4 The complete text of the Nondiscrimination Certification is available electronically in the Grant Proposal Guide, Chapter II, Exhibit II-6. 5 In addition to vertebrate animals covered by the Animal Welfare Act, the requirements specified in this Article also are extended to rats, birds and mice.
Research Involving Recombinant DNA Molecules. [RESERVED]
Research Involving Recombinant DNA Molecules. (A) Applicability: This section applies to all research, for which CRDF grant funds are used, that falls within the scope of the Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) (Federal Register/Vol. 59, No. 127, July 5, 1994, 34495- 34547), as amended, hereafter referred to as the "Guidelines".
Research Involving Recombinant DNA Molecules. If an award issued under this Arrangement supports research involving recombinant DNA molecules, CRDF agrees, and shall require the awardee to agree, to comply with the requirements of the NSF Award and Administration Guide (AAG) Chapter VI.B.2. This section applies to all research, for which NSF grant funds are used, that falls within the scope of the Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), xxxx://xxxxxx.xxx.xxx/grants/guide/notice-files/NOT-OD-02-052.html as amended in April 2002, hereafter referred to as the “Guidelines”. Recombinant DNA Research Outside the U.S. Recombinant DNA research within the scope of the Guidelines that is performed outside of the U.S. using funds provided by NSF for transportation, salaries or direct research expenses must comply with the U.S. or host country standards. If the research is to be carried out in a country that has adopted guidelines comparable to those of the U.S., a document with information and endorsements assuring compliance to the host organization standards must be submitted to NSF. NSF funds may not be used to carry out research using recombinant DNA in a country that has not adopted national guidelines unless the research is in full compliance with the Guidelines and the procedures required for NSF-supported research within the United States.
Research Involving Recombinant DNA Molecules. If an award issued under this Arrangement supports research involving recombinant DNA molecules, CRDF agrees, and shall require the awardee to agree, to comply with the requirements of the NSF Award and Administration Guide (AAG) Chapter VI.B.2. This section applies to all research, for which NSF grant funds are used, that falls within the scope of the Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), xxxx://xxxxxx.xxx.xxx/grants/guide/notice-files/NOT-OD-02-052.html as amended in April 2002, hereafter referred to as the “Guidelines”. Recombinant DNA Research Outside the U.S. Recombinant DNA research within the scope of the Guidelines that is performed outside of the U.S. using funds provided by NSF for transportation, salaries or direct research expenses must comply with the U.S. or host country standards. If the research is to be carried out in a country that has adopted guidelines comparable to those of the U.S., a document with information and endorsements assuring compliance to the host organization standards must be submitted to NSF. NSF funds may not be used to carry out research using recombinant DNA in a country that has not adopted national guidelines unless the research is in full compliance with the Guidelines and the procedures required for NSF-supported research within the United States.
AutoNDA by SimpleDocs

Related to Research Involving Recombinant DNA Molecules

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

Time is Money Join Law Insider Premium to draft better contracts faster.